Advertisement
Screener

OMNIAB, INC. (OABI) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

OmniAb, Inc. Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • OmniAb, Inc. return tang equity for the quarter ending 2026-06-30 was -73.51%, a change of 63.15% year-over-year.
  • OmniAb, Inc. return tang equity for the quarter ending 2026-03-31 was -91.17%, a change of 20.84% year-over-year.
  • OmniAb, Inc. return tang equity for the quarter ending 2025-12-31 was -111.88%, a change of -17.29% year-over-year.
  • OmniAb, Inc. return tang equity for the quarter ending 2025-09-30 was -97.82%, a change of 1.22% year-over-year.
  • OmniAb, Inc. return tang equity for fiscal 2025 was -111.88%, a change of -17.29% from fiscal 2024.
  • OmniAb, Inc. return tang equity for fiscal 2024 was -94.59%, a change of -27.23% from fiscal 2023.
  • OmniAb, Inc. return tang equity for fiscal 2023 was -67.37%, a change of -42.59% from fiscal 2022.
  • OmniAb, Inc. return tang equity for fiscal 2022 was -24.77%, a change of -6.79% from fiscal 2021.
Available history
2021-12-31 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-06-30-73.51%-$44.27M$60.23M
2026-03-31-91.17%-$54.29M$59.55M
2025-12-31-111.88%-$64.78M$57.9M
2025-09-30-97.82%-$63.67M$65.09M
2025-06-30-136.65%-$63.52M$46.48M
2025-03-31-112.01%-$61.27M$54.7M
2024-12-31-94.59%-$62.03M$65.58M
2024-09-30-99.04%-$63.02M$63.63M
2024-06-30-99.51%-$62.38M$62.69M
2024-03-31-97.13%-$63.48M$65.36M
2023-12-31-67.37%-$50.62M$75.14M
2023-09-30-36.37%-$29.75M$81.8M
2023-06-30-30.26%-$26.6M$87.91M
2023-03-31-23.96%-$22.15M$92.47M
2022-12-31-24.77%-$22.33M$90.15M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-31-111.88%-$64.78M$57.9M
2024-12-31-94.59%-$62.03M$65.58M
2023-12-31-67.37%-$50.62M$75.14M
2022-12-31-24.77%-$22.33M$90.15M
2021-12-31-17.99%-$27.04M$150.33M

Similar stocks

Stock NameCountryMarket CapPE Ratio
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
Absci Corp (ABSI)United States$1.775B-14.92
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14